Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins

被引:178
作者
Donoghue, M
Wakimoto, H
Maguire, CT
Acton, S
Hales, P
Stagliano, N
Fairchild-Huntress, V
Xu, J
Lorenz, JN
Kadambi, V
Berul, CI
Breitbart, RE [1 ]
机构
[1] Millennium Pharmaceut Inc, Cambridge, MA USA
[2] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[3] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA
[4] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH USA
关键词
ACE2; heart block; sudden death; connexins; transgenic mice;
D O I
10.1016/S0022-2828(03)00177-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Angiotensin converting enzyme related carboxypeptidase (ACE2) is a recently discovered homolog of angiotensin converting enzyme with tissue-restricted expression, including heart, and the capacity to cleave angiotensin peptides. We tested the hypothesis that cardiac ACE2 activity contributes to features of ventricular remodeling associated with the renin-angiotensin system by generating transgenic mice with increased cardiac ACE2 expression. These animals had a high incidence of sudden death that correlated with transgene expression levels. Detailed electrophysiology revealed severe, progressive conduction and rhythm disturbances with sustained ventricular tachycardia and terminal ventricular fibrillation. The gap junction proteins connexin40 and connexin43 were downregulated in the transgenic hearts, indicating that ACE2-mediated gap junction remodeling may account for the observed electrophysiologic disturbances. Spontaneous downregulation of the ACE2 transgene in surviving older animals correlated with restoration of nearly normal conduction, rhythm, and connexin expression. (C) 2003 Published by Elsevier Ltd.
引用
收藏
页码:1043 / 1053
页数:11
相关论文
共 47 条
[1]  
BEDDINGTON RSP, 1989, DEVELOPMENT, V106, P37
[2]   DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model [J].
Berul, CI ;
Maguire, CT ;
Aronovitz, MJ ;
Greenwood, J ;
Miller, C ;
Gehrmann, J ;
Housman, D ;
Mendelsohn, ME ;
Reddy, S .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (04) :R1-R7
[3]   In vivo cardiac electrophysiology studies in the mouse [J].
Berul, CI ;
Aronovitz, MJ ;
Wang, PJ ;
Mendelsohn, ME .
CIRCULATION, 1996, 94 (10) :2641-2648
[4]   A targeted disruption in connexin40 leads to distinct atrioventricular conduction defects [J].
Bevilacqua, LM ;
Simon, AM ;
Maguire, CT ;
Gehrmann, J ;
Wakimoto, H ;
Paul, DL ;
Berul, CI .
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2000, 4 (03) :459-467
[5]  
Blaufarb Ira S., 1996, American Journal of Cardiology, V77, p8C, DOI 10.1016/S0002-9149(96)00183-X
[6]   Angiotensin-converting enzyme 2 is an essential regulator of heart function [J].
Crackower, MA ;
Sarao, R ;
Oudit, GY ;
Yagil, C ;
Kozieradzki, I ;
Scanga, SE ;
Oliveira-dos-Santos, AJ ;
da Costa, J ;
Zhang, LY ;
Pei, Y ;
Scholey, J ;
Ferrario, CM ;
Manoukian, AS ;
Chappell, MC ;
Backx, PH ;
Yagil, Y ;
Penninger, JM .
NATURE, 2002, 417 (6891) :822-828
[7]   Contractile adaptations preserving cardiac output predispose the hypertrophied canine heart to delayed afterdepolarization-dependent ventricular arrhythmias [J].
de Groot, SHM ;
Schoenmakers, M ;
Molenschot, MMC ;
Leunissen, JDM ;
Wellens, HJJ ;
Vos, MA .
CIRCULATION, 2000, 102 (17) :2145-2151
[8]  
De Mello W C, 1997, J Card Fail, V3, P53, DOI 10.1016/S1071-9164(97)90008-7
[9]   Correlation between changes in morphology, electrical properties, and angiotensin-converting enzyme activity in the failing heart [J].
de Mello, WC ;
Crespo, MJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 378 (02) :187-194
[10]  
de Mello WC, 1999, J CARDIOVASC ELECTR, V10, P1409, DOI 10.1111/j.1540-8167.1999.tb00197.x